SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Durect (DRRX)

DRRX RSS Feed
Add DRRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/20/2017 10:46:26 PM - Followers: 70 - Board type: Free - Posts Today: 0

http://www.durect.com/

http://finance.yahoo.com/q/ks?s=DRRX

DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies. The company?s products include POSIDUR, a release formulation of bupivacaine under Phase IIb clinical trial, which is used for the treatment of post-surgical pain; and ELADUR, a transdermal bupivacaine patch under Phase IIb clinical trial that provides continuous delivery of bupivacaine for up to three days from a single application, as well as is used for the treatment of pain associated with post-herpetic neuralgia. It also offers Remoxy, an oral oxycodone gelatin capsule under development with pain therapeutics; and TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch under development, which provides continuous delivery of sufentanil for a period of up to seven days from a single application. In addition, the company offers CHRONOGESIC (sufentanil), a pain therapy system; and ALZET, the miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals, as well as conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. Further, it designs, develops, and manufactures various biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients for use as raw materials in their products. The company has collaboration agreements with Alpharma Ireland Limited; Nycomed Danmark, APS; Pain Therapeutics, Inc.; Endo Pharmaceuticals Inc; Voyager Pharmaceutical Corporation; ALZA Corporation; EpiCept Corporation; and NeuroSystec Corporation. DURECT Corporation was founded in 1998 and is based in Cupertino, CA.

SureTrader
Interactive Brokers Advertisement
DRRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DRRX News: Current Report Filing (8-k) 10/20/2017 06:08:19 AM
DRRX News: DURECT Announces Top-line Results from the PERSIST Phase 3 Trial of POSIMIR® (SABER®-Bupivacaine) Did Not Meet Primary Effi... 10/19/2017 05:57:00 PM
DRRX News: Amended Current Report Filing (8-k/a) 10/02/2017 05:24:47 PM
DRRX News: Current Report Filing (8-k) 10/02/2017 06:31:07 AM
DRRX News: DURECT and Indivior PLC Sign a $17.5 Million Patent Purchase Agreement 10/02/2017 02:05:00 AM
PostSubject
#699   Looks like we start over again with at north40000 10/20/17 10:46:26 PM
#698   wow look at the losses that's crazy what happened jonyroxy 10/20/17 05:43:36 PM
#697   * * $DRRX Video Chart 10-20-17 * * ClayTrader 10/20/17 04:45:26 PM
#696   Tomorrow it is Saterday. Enjoy your weekend. declaes 10/20/17 03:47:44 PM
#695   DURECT Announces Top-line Results from the PERSIST Phase realfast95 10/19/17 06:48:47 PM
#694   a setback for sure, but this co has dirtydozen911 10/19/17 06:45:05 PM
#693   dirtydozen911 10/19/17 05:47:37 PM
#692   Acad blockbuster was Alzheimer’s drug I believe Youlie 10/07/17 10:27:05 AM
#691   I don't follow ACAD. However Durect and realfast95 10/06/17 01:00:10 PM
#690   Does the indication specified in that NDA represent north40000 10/06/17 12:20:22 PM
#689   Zacks take realfast95 10/05/17 03:50:51 PM
#688   They’re going to try to shake it hard Youlie 10/04/17 05:06:53 PM
#687   I hope everyone held on the tree securely. realfast95 10/04/17 11:12:36 AM
#686   it's hard to say if it keeps going realfast95 10/04/17 06:24:43 AM
#685   you expect this to keep going north from here? madras50 10/03/17 09:13:30 PM
#684   boom lift off! realfast95 10/03/17 02:35:12 PM
#683   amendment to agreement realfast95 10/02/17 09:35:57 PM
#682   BREAKOUT WATCH for possible breakout above 1.9, no resistance realfast95 10/02/17 04:21:07 PM
#681   On September 26, 2017, DURECT Corporation (“DURECT” or realfast95 10/02/17 07:00:30 AM
#680   Seeking Alpha - slides from Cantor realfast95 09/27/17 02:26:46 PM
#679   they changed the day and time at the realfast95 09/25/17 05:51:51 PM
#678   it was disclosed in the 8K today realfast95 09/20/17 06:50:51 PM
#677   Figured so Youlie 09/20/17 06:43:00 PM
#676   Dr. Myriam Theeuwes is the daughter of Dr. realfast95 09/20/17 05:54:15 PM
#675   DURECT Appoints Dr. Myriam Theeuwes as Senior Vice realfast95 09/20/17 08:10:40 AM
#674   I'll be buying up weekly Youlie 09/13/17 12:26:12 PM
#673   Next 12 months realfast95 09/13/17 12:22:36 PM
#672   CUPERTINO, Calif., Sept. 5, 2017 /PRNewswire/ -- DURECT realfast95 09/05/17 04:28:14 PM
#671   Patent Application realfast95 09/05/17 06:52:13 AM
#670   There non-opioid pain medication is a game changer, mpp1 08/14/17 02:19:15 PM
#669   zacks realfast95 08/11/17 10:34:19 AM
#668   $PTIE earnings report update on $DRRX product realfast95 08/09/17 01:16:55 PM
#667   Earnings -.07 on rev of 4.3m realfast95 08/08/17 04:40:49 PM
#666   ORADUR®-Methylphenidate ER Capsule Achieves Primary Endpoint in Phase realfast95 08/08/17 09:38:38 AM
#665   DRRX Q2 - Tue Aug 8th 4:30pm est realfast95 08/06/17 02:58:40 PM
#664   Item 1.02. Termination of a Material Definitive Agreement realfast95 08/02/17 05:12:26 PM
#663   should rise steady into cc on 8/7.....keep in dirtydozen911 08/01/17 04:46:31 PM
#662   We expecting a move this week? wagz 08/01/17 04:38:33 PM
#661   Item 1.02. Termination of a Material Definitive Agreement realfast95 07/28/17 04:13:42 PM
#660   IPCI failure to get FDA approval should be realfast95 07/27/17 09:46:16 AM
#659   Progress in Pain Control and Liver Disease Programs realfast95 07/19/17 04:57:06 PM
#658   follow up: Designated status, was given 7/6/17 to realfast95 07/19/17 11:29:39 AM
#657   quite the run. On May 31st it closed realfast95 07/18/17 02:09:56 PM
#656   Put buyers may have placed a short term realfast95 07/16/17 03:49:10 PM
#655   it was just marked 7/6 it's not already realfast95 07/12/17 02:12:09 PM
#654   Doubt they will PR it. It's known already. Youlie 07/12/17 01:44:05 PM
#653   DRRX has not issued a press release on realfast95 07/12/17 01:04:05 PM
#652   That should say Designated status, not approved realfast95 07/12/17 10:14:17 AM
#651   $DRRX (+2.5% pre) DURECT Corp primary sclerosing cholangitis realfast95 07/12/17 07:43:09 AM
#650   Stifel transitions coverage and upgraded Durect Corp (NASDAQ: realfast95 07/12/17 07:41:05 AM
PostSubject